33 results on '"Inagaki, Yosuke"'
Search Results
2. Phase 2 study of upacicalcet in Japanese haemodialysis patients with secondary hyperparathyroidism: an intraindividual dose-adjustment study.
- Author
-
Inaguma, Daijo, Koiwa, Fumihiko, Tokumoto, Masanori, Fukagawa, Masafumi, Yoneda, Shinji, Yasuzawa, Hisami, Asano, Kenji, Hagita, Keiko, Inagaki, Yosuke, Honda, Daisuke, and Akizawa, Tadao
- Subjects
HEMODIALYSIS patients ,DRUG side effects ,HYPERPARATHYROIDISM ,INTRAVENOUS injections ,EDUCATIONAL attainment - Abstract
Background Upacicalcet is a novel small-molecule calcimimetic agent developed for intravenous injection. Here, we evaluated the long-term efficacy and safety of upacicalcet treatment via intraindividual dose adjustment in haemodialysis patients with secondary hyperparathyroidism (SHPT). Methods A phase 2, multicentre, open-label, single-arm study was conducted. Upacicalcet was administered for 52 weeks; the starting dose was 50 μg thrice a week, and then adjusted to 25, 50, 100, 150, 200, 250, or 300 μg, according to the dose-adjustment method set in the protocol. The primary endpoint was the percentage of patients with serum intact parathyroid hormone (iPTH) level achieving a target range of 60–240 pg/mL (target achievement rate) at week 18. Results A total of 58 patients were administered upacicalcet. The target achievement rate of serum iPTH level at week 18 was 57.9%, which increased to 80.8% at week 52. The serum-corrected calcium (cCa) level decreased immediately after upacicalcet administration, but no further decrease was observed. Adverse events were observed in 94.8% of patients, and adverse drug reactions (ADRs) occurred in 20.7% of patients. The most common ADR was decreased adjusted calcium in eight patients; dizziness occurred as a serious ADR in one patient. The serum cCa level of patients who interrupted upacicalcet treatment at a serum cCa level of <7.5 mg/dL recovered to ≥7.5 mg/dL immediately after the interruption. Conclusions In haemodialysis patients with SHPT, upacicalcet doses of 25–300 μg for 52 weeks were found to be highly effective and well-tolerated, with minor safety concerns. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Higenamine 4′-O-β-d-glucoside in the lotus plumule induces glucose uptake of L6 cells through β2-adrenergic receptor
- Author
-
Kato, Eisuke, Inagaki, Yosuke, and Kawabata, Jun
- Published
- 2015
- Full Text
- View/download PDF
4. CS-866, a New Angiotensin II Type 1 Receptor Antagonist, Ameliorates Glomerular Anionic Site Loss and Prevents Progression of Diabetic Nephropathy in Otsuka Long-Evans Tokushima Fatty Rats
- Author
-
Koga, Kohachiro, Yamagishi, Sho-ichi, Takeuchi, Masayoshi, Inagaki, Yosuke, Amano, Shinjiro, Okamoto, Tamami, Saga, Tsuyoshi, Makita, Zenji, and Yoshizuka, Mitsuaki
- Published
- 2002
- Full Text
- View/download PDF
5. Beraprost Sodium, a Prostaglandin I2 Analogue, Protects Against Advanced Glycation End Products-induced Injury in Cultured Retinal Pericytes
- Author
-
Yamagishi, Sho-ichi, Amano, Shinjiro, Inagaki, Yosuke, Okamoto, Tamami, Takeuchi, Masayoshi, and Makita, Zenji
- Published
- 2002
- Full Text
- View/download PDF
6. Palmitate-Induced Apoptosis of Microvascular Endothelial Cells and Pericytes
- Author
-
Yamagishi, Sho-ichi, Okamoto, Tamami, Amano, Shinjiro, Inagaki, Yosuke, Koga, Kohachiro, Koga, Mari, Choei, Hiroshi, Sasaki, Nobuyuki, Kikuchi, Seiji, Takeuchi, Masayoshi, and Makita, Zenji
- Published
- 2002
- Full Text
- View/download PDF
7. Pigment epithelium-derived factor inhibits TNF-α-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation
- Author
-
Yamagishi, Sho-Ichi, Inagaki, Yosuke, Nakamura, Kazuo, Abe, Riichiro, Shimizu, Tadamichi, Yoshimura, Akihiko, and Imaizumi, Tsutomu
- Published
- 2004
- Full Text
- View/download PDF
8. AGEs activate mesangial TGF-β–Smad signaling via an angiotensin II type I receptor interaction
- Author
-
FUKAMI, KEI, UEDA, SEIJI, YAMAGISHI, SHO-ICHI, KATO, SEIYA, INAGAKI, YOSUKE, TAKEUCHI, MASAYOSHI, MOTOMIYA, YOSHIHIRO, BUCALA, RICHARD, IIDA, SHUJI, TAMAKI, KIYOSHI, IMAIZUMI, TSUTOMU, COOPER, MARK E., and OKUDA, SEIYA
- Published
- 2004
9. Neurotoxicity of Acetaldehyde-Derived Advanced Glycation End Products for Cultured Cortical Neurons
- Author
-
TAKEUCHI, MASAYOSHI, WATAI, TAKAYUKI, SASAKI, NOBUYUKI, CHOEI, HIROSHI, IWAKI, MINA, ASHIZAWA, TAKESHI, INAGAKI, YOSUKE, YAMAGISHI, SHO-ICHI, KIKUCHI, SEIJI, RIEDERER, PETER, SAITO, TOSHIKAZU, BUCALA, RICHARD, and KAMEDA, YUKIHIKO
- Published
- 2003
10. Advanced glycation end products inhibit de novo protein synthesis and induce TGF-β overexpression in proximal tubular cells
- Author
-
YAMAGISHI, SHO-ICHI, INAGAKI, YOSUKE, OKAMOTO, TAMAMI, AMANO, SHINJIRO, KOGA, KOHACHIRO, and TAKEUCHI, MASAYOSHI
- Published
- 2003
11. Astilbe thunbergii reduces postprandial hyperglycemia in a type 2 diabetes rat model via pancreatic alpha-amylase inhibition by highly condensed procyanidins.
- Author
-
Kato, Eisuke, Kushibiki, Natsuka, Inagaki, Yosuke, Kurokawa, Mihoko, and Kawabata, Jun
- Subjects
PROCYANIDINS ,ASTILBE ,SAXIFRAGACEAE - Abstract
Type 2 diabetes mellitus (T2DM) is a common global health problem. Prevention of this disease is an important task, and functional food supplements are considered an effective method. We found potent pancreatic α-amylase inhibition inAstilbe thunbergiiroot extract (AT) and confirmed that AT treatment in a T2DM rat model reduces post-starch administration blood glucose levels. Activity-guided isolation revealed procyanidin (AT-P) as the α-amylase inhibitory component with IC50 = 1.7 μg/mL against porcine pancreatic α-amylase. Structure analysis of AT-P revealed it is a B-type procyanidin comprised of four types of flavan-3-ols, some with a galloyl group, and catechin attached as the terminal unit. The abundant AT-P content and its comparable α-amylase inhibition to acarbose, the anti-diabetic medicine, suggest that AT is a promising food supplement for diabetes prevention. Astilbe thunbergiiextract showed anti-diabetic effect against type-2 diabetes mellitus rat model. Procyanidin was isolated as an active compound with potent α-amylase inhibition. [ABSTRACT FROM PUBLISHER]
- Published
- 2017
- Full Text
- View/download PDF
12. The apparent counter diffusion coefficient of water absorbing on zeolite particles in the case of the water moving through macro-size pores in a column packed with zeolite particles.
- Author
-
Ogawa, Kuniyasu and Inagaki, Yosuke
- Subjects
- *
DIFFUSION coefficients , *ZEOLITES , *ABSORPTION , *PORE size (Materials) , *WATER , *PACKED towers (Chemical engineering) , *OXYGEN - Abstract
The oxygen concentration discharged from a compact adsorption-type oxygen concentrator decreases when water attaches to the zeolite particles used as a nitrogen adsorbent. In order to estimate the expansion of the water adsorption region in the zeolite column, it is necessary to measure the water diffusion occurring in a zeolite column after stopping PSA (Pressure Swing Adsorption) operations. Li-X type zeolite particles (molecular sieve OXYSIV-700) with particle diameters in the range of approximately 0.4–0.5 mm were used as a nitrogen adsorbent column of length 157 mm and of inner diameter 33 mm. By comparing the water concentration distributions obtained from MR (Magnetic Resonance) images and the distributions calculated by analytical solution of a one-dimensional diffusion equation under transient conditions, the counter diffusion coefficient of water absorbing on zeolite particles in the column was determined. The apparent diffusion coefficient of water absorbing on the zeolite particles moving into the zeolite column with macroscale pores was determined to be 1.25 ± 0.15 × 10 −11 m 2 /s. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
13. Isolation of rugosin A, B and related compounds as dipeptidyl peptidase-IV inhibitors from rose bud extract powder.
- Author
-
Kato, Eisuke, Uenishi, Yuta, Inagaki, Yosuke, Kurokawa, Mihoko, and Kawabata, Jun
- Subjects
CD26 antigen ,COMPOSITION of roses ,PLANT extracts - Abstract
Dipeptidyl peptidase-IV (DPP-IV) is a protease responsible for the degradation of the incretin hormone. A number of DPP-IV inhibitors have been approved for use in the treatment of type 2 diabetes. While these inhibitors are effective for this treatment, methods for the prevention of this disease are also required as diabetes patient numbers are currently increasing rapidly worldwide. We screened the DPP-IV inhibitory activities of edible plant extracts with the intention of using these extracts in a functional food supplement for the prevention of diabetes. Rose (Rosa gallica) bud extract powder was a promising material with high inhibitory activity. In this study, seven ellagitannins were isolated as active compounds through activity-guided fractionations, and their DPP-IV inhibitory activities were measured. Among them, rugosin A and B showed the highest inhibitory activities and rugosin B was shown as the major contributing compound in rose bud extract powder. Ellagitannins were isolated as DPP-IV inhibitors from rose bud extract powder. Compounds with the valoneoyl group showed high inhibitory activity. [ABSTRACT FROM PUBLISHER]
- Published
- 2016
- Full Text
- View/download PDF
14. Advanced Glycation End-Products Attenuate Human Mesenchymal Stem Cells and Prevent Cognate Differentiation Into Adipose Tissue, Cartilage, and Bone.
- Author
-
Kume, Shinichiro, Kato, Seiya, Yamagishi, Sho-ichi, Inagaki, Yosuke, Ueda, Seiji, Arima, Nobuyuki, Okawa, Takahiro, Kojiro, Masamichi, and Nagata, Kensei
- Published
- 2005
- Full Text
- View/download PDF
15. Interferon-γ-induced apoptosis and activation of THP-1 macrophages
- Author
-
Inagaki, Yosuke, Yamagishi, Sho-ichi, Amano, Shinjiro, Okamoto, Tamami, Koga, Kohachiro, and Makita, Zenji
- Subjects
- *
MACROPHAGES , *ATHEROSCLEROSIS - Abstract
Apoptotic macrophages are frequently observed in human atherosclerotic lesions, and are considered to be involved in plaque instability in atherosclerosis. However, the molecular mechanism that promotes programmed cell death of macrophages in atherosclerosis remains to be elucidated. In this study, we investigated the effects of interferon-γ (IFN-γ), a cytokine secreted by activated T helper 1 (Th1) lymphocytes, on apoptotic cell death of THP-1 macrophages. Further we studied whether these apoptotic macrophages could be simultaneously activated in vitro and subsequently overgenerate monocyte chemoattractant protein-1 (MCP-1). When THP-1 macrophages were cultured with various concentrations of IFN-γ, DNA synthesis was significantly decreased. IFN-γ was found significantly to induce apoptotic cell death in THP-1 macrophages. RNase protection assay revealed that IFN-γ up-regulated the mRNA levels of two pro-apoptotic molecules, tumor necrosis factor-α receptor 1 (TNFR1) and caspase-8, in THP-1 cells. Furthermore, TNF-α antibodies were found completely to neutralize the IFN-γ-induced inhibition in DNA synthesis as well as apoptotic cell death in macrophages. IFN-γ was found to activate these macrophages to stimulate MCP-1 production. The results suggest that IFN-γ not only exerted apoptotic effects on macrophages, but also activated them and subsequently overgenerated MCP-1, and was thus involved in the development and progression of atherosclerosis. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
16. Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties
- Author
-
Yamagishi, Sho-ichi, Inagaki, Yosuke, Amano, Shinjiro, Okamoto, Tamami, Takeuchi, Masayoshi, and Makita, Zenji
- Subjects
- *
NEOVASCULARIZATION , *DIABETIC retinopathy - Abstract
Pigment epithelium-derived factor (PEDF) has recently been shown to be the most potent inhibitor of angiogenesis in the mammalian eye, suggesting that loss of PEDF is involved in the pathogenesis of proliferative diabetic retinopathy. However, a protective role for PEDF in pericyte loss in early diabetic retinopathy remains to be elucidated. In this study, we investigated whether PEDF proteins could protect against advanced glycation end product (AGE)-induced injury in retinal pericytes. Ligand blot analysis revealed that pericytes possessed a membrane protein with binding affinity for PEDF. PEDF proteins were found to significantly inhibit AGE-induced reactive oxygen species (ROS) generation and the subsequent decrease in DNA synthesis and apoptotic cell death in pericytes. Further, PEDF proteins completely restored the down-regulation of bcl-2 gene expression in AGE-exposed pericytes. The results demonstrated that PEDF proteins protected cultured pericytes from AGE-induced cytotoxicity through its anti-oxidative properties. Our present study suggests that substitution of PEDF proteins may be a promising strategy in treatment of patients with early diabetic retinopathy. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
17. Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin.
- Author
-
Okamoto, Tamami, Yamagishi, Sho‐ichi, Inagaki, Yosuke, Amano, Shinjiro, Koga, Kohachiro, Abe, Riichiro, Takeuchi, Masayoshi, Ohno, Shigeaki, Yoshimura, Akihiko, and Makita, Zenji
- Published
- 2002
- Full Text
- View/download PDF
18. Response functions of a Si(Li) detector for 1.3–4.0 keV monochromatic photons
- Author
-
Inagaki, Yosuke, Shima, Kunihiro, and Maezawa, Hideki
- Published
- 1987
- Full Text
- View/download PDF
19. SOX6 Suppresses Cyclin D1 Promoter Activity by Interacting with β-Catenin and Histone Deacetylase 1, and Its Down-regulation Induces Pancreatic β-Cell ProIiferation.
- Author
-
Iguchi, Haruhisa, Urashima, Yasuyo, Inagaki, Yosuke, Ikeda, Yukio, Okamura, Masashi, Tanaka, Toshiya, Uchida, Aoi, Yamamoto, Tokuo T., Kodama, Tatsuhiko, and Sakai, Juro
- Subjects
- *
CELL proliferation , *PROMOTERS (Genetics) , *INSULIN resistance , *PANCREATIC beta cells , *HISTONE deacetylase , *TRANSCRIPTION factors , *RNA - Abstract
Sex-determining region Y-box (SOX) 6 negatively regulates glucose-stimulated insulin secretion from β-cells and is a down- regulated transcription factor in the pancreatic islet cells of hyperinsulinemic obese mice. To determine the contribution of SOX6 to insulin resistance, we analyzed the effects of SOX6 on cell proliferation. Small interfering RNA-mediated attenuation of SOX6 expression stimulated the proliferation of insulinoma INS-1E and NIH-3T3 cells, whereas retroviral overexpression resulted in inhibition of cell growth. Quantitative real time-PCR analysis revealed that the levels of cyclin D1 transcripts were markedly decreased by SOX6 overexpression. Luciferase-reporter assay with β-catenin showed that SOX6 suppresses cyclin D1 promoter activities. In vitro binding experiments showed that the LZ/Q domain of SOX6 physically interacts with armadillo repeats 1-4 of β-catenin. Furthermore, chromatin immunoprecipitation assay revealed that increased SOX6 expression significantly reduced the levels of acetylated histones H3 and H4 at the cyclin D1 promoter. By using a histone deacetylase (HDAC) inhibitor and co-immunoprecipitation analysis, we showed that SOX6 suppressed cyclin D1 activities by interacting with β-catenin and HDAC1. The data presented suggest that SOX6 may be an important factor in obesity-related insulin resistance. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
20. Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes
- Author
-
Amano, Shinjiro, Yamagishi, Sho-ichi, Inagaki, Yosuke, Nakamura, Kazuo, Takeuchi, Masayoshi, Inoue, Hiroyoshi, and Imaizumi, Tsutomu
- Subjects
- *
GLUCOSE , *MESSENGER RNA , *RETINAL diseases , *REACTIVE oxygen species - Abstract
Abstract: Pigment epithelium-derived factor (PEDF) is a potent inhibitor of angiogenesis in the mammalian eye, suggesting that loss of PEDF is implicated in the pathogenesis of proliferative diabetic retinopathy. However, a role for PEDF in early diabetic retinopathy remains to be elucidated. Since oxidative stress is thought to be involved in pericyte loss and dysfunction, one of the changes characteristic of early diabetic retinopathy, we investigated whether and how PEDF could protect cultured retinal pericyte against oxidative stress injury. High glucose (30 mM) increased intracellular reactive oxygen species (ROS) generation in pericytes, which was completely blocked by PEDF. High glucose or H2O2 was found to induce growth retardation and apoptotic cell death of pericytes. PEDF completely restored these cytopathic effects on pericytes. An increased ratio of bax to bcl-2 mRNA level with subsequent activation of caspase-3 was observed in high-glucose- or H2O2-exposed pericytes, which was also completely prevented by PEDF. PEDF significantly increased glutathione peroxidase (GPx) mRNA levels and activity in pericytes. Further, PEDF was found to completely inhibit high-glucose- or H2O2-induced increase in a mRNA ratio of angiopoietin-2 to angiopoietin-1 and up-regulation of VEGF mRNA levels in pericytes. PEDF mRNA levels themselves were down-regulated in high-glucose- or H2O2-exposed pericytes. These results demonstrate that PEDF protects against high-glucose- or H2O2-induced pericyte apoptosis and dysfunction through its anti-oxidative properties via GPx induction. Our present study suggests that substitution of PEDF proteins might be a promising therapeutic strategy for treatment of patients with early diabetic retinopathy. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
21. Pigment epithelium-derived factor inhibits leptin-induced angiogenesis by suppressing vascular endothelial growth factor gene expression through anti-oxidative properties
- Author
-
Yamagishi, Sho-ichi, Amano, Shinjiro, Inagaki, Yosuke, Okamoto, Tamami, Takeuchi, Masayoshi, and Inoue, Hiroyoshi
- Subjects
- *
LEPTIN , *NEOVASCULARIZATION , *GROWTH factors - Abstract
Leptin, a circulating hormone secreted mainly from adipose tissues, is involved in the control of body weight. Recently, leptin was found to be an angiogenic factor, and its vitreous levels are associated with angiogenic eye diseases such as proliferative diabetic retinopathy. However, the molecular mechanism for leptin-elicited angiogenesis remains to be elucidated. Pigment epithelium-derived factor (PEDF) has been shown to be the most potent natural inhibitor of angiogenesis in the mammalian eye, and its levels in the vitreous were decreased in angiogenic eye diseases. In this study, we investigated whether and how PEDF could inhibit the leptin-induced DNA synthesis in microvascular endothelial cells (EC), a key step of angiogenesis. Leptin significantly increased intracellular reactive oxygen species (ROS) generation in microvascular EC. PEDF was found to inhibit the leptin-induced ROS generation in EC. An anti-oxidant, N-acetylcysteine, or PEDF completely prevented the leptin-induced upregulation of vascular endothelial growth factor (VEGF) mRNA levels as well as any increase in DNA synthesis in microvascular EC. Polyclonal antibodies against human VEGF were also found to completely inhibit DNA synthesis in leptin-exposed EC. The present study suggests that leptin could elicit angiogenesis through autocrine VEGF production via intracellular ROS generation. PEDF may block the angiogenic effects of leptin through its anti-oxidative properties. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
22. Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro
- Author
-
Okamoto, Tamami, Yamagishi, Sho-ichi, Inagaki, Yosuke, Amano, Shinjiro, Takeuchi, Masayoshi, Kikuchi, Seiji, Ohno, Shigeaki, and Yoshimura, Akihiko
- Subjects
- *
NEOVASCULARIZATION , *DIABETIC retinopathy - Abstract
We have previously shown that advanced glycation end products (AGE), senescent macroprotein derivatives formed at an accelerated rate in diabetes, induced angiogenesis through overgeneration of autocrine vascular endothelial growth factor (VEGF). In the present study, effects of incadronate disodium, a nitrogen-containing bisphosphonate on AGE-elicited angiogenesis in vitro, were studied. Incadronate disodium was found to completely inhibit AGE-induced increase in DNA synthesis as well as tube formation of human microvascular endothelial cells (EC). Furthermore, incadronate disodium significantly prevented transcriptional activation of nuclear factor-
κ B and activator protein-1 and the subsequent up-regulation of VEGF mRNA levels in AGE-exposed EC. Farnesyl pyrophosphate, but not geranylgeranyl pyrophosphate, was found to completely restore the anti-angiogenic effects of incadronate disodium on EC. These results suggest that incadronate disodium could block the AGE-signaling pathway in microvascular EC through inhibition of protein farnesylation. Incadronate disodium may be a promising remedy for treatment of patients with proliferative diabetic retinopathy. [Copyright &y& Elsevier]- Published
- 2002
- Full Text
- View/download PDF
23. Advanced Glycation End Products-Induced Apoptosis and Overexpression of Vascular Endothelial Growth Factor in Bovine Retinal Pericytes
- Author
-
Yamagishi, Sho-ichi, Amano, Shinjiro, Inagaki, Yosuke, Okamoto, Tamami, Koga, Kohachiro, Sasaki, Nobuyuki, Yamamoto, Hiroshi, Takeuchi, Masayoshi, and Makita, Zenji
- Subjects
- *
GENE expression , *GROWTH factors - Abstract
The influence of advanced glycation end products (AGEs) on apoptotic cell death and vascular endothelial growth factor (VEGF) gene expression in cultured bovine retinal pericytes was investigated. When pericytes were incubated with three immunochemically distinct AGEs, which were prepared in vitro by incubating bovine serum albumin with glucose, glyceraldehyde, or glycolaldehyde, apoptotic cell death and DNA ladder formation were significantly induced. The cytopathic effects of glyceraldehyde- or glycolaldehyde-derived AGEs were significantly enhanced in AGE receptor-transfected pericytes. Furthermore, all of these AGEs were found to upregulate the secretory forms of VEGF mRNA levels in retinal pericytes. These results suggest that AGEs disturbed retinal microvascular homeostasis by inducing pericyte apoptosis and VEGF overproduction and thus were involved in the pathogenesis of early phase diabetic retinopathy. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
24. Pigment Epithelium-derived Factor Inhibits Advanced Glycation End Product-induced Retinal Vascular Hyperpermeability by Blocking Reactive Oxygen Species- mediated Vascular Endothelial Growth Factor Expression.
- Author
-
Yamagishi, Sho-Ichi, Nakamura, Kazuo, Matsui, Takanori, Inagaki, Yosuke, Takenaka, Katsuhiko, Jinnouchi, Yuko, Yoshida, Yumiko, Matsuura, Tetsuro, Narama, Isao, Motomiya, Yoshihiro, Takeuchi, Masayoshi, Inoue, Hiroyoshi, Yoshimura, Akihiko, Bucala, Richard, and Imaizumi, Tsutomu
- Subjects
- *
DIABETES complications , *RETINOIDS , *VASCULAR endothelial growth factors , *CELLULAR control mechanisms , *ADSORPTION (Chemistry) , *DIABETIC retinopathy , *NEOVASCULARIZATION , *PEOPLE with diabetes - Abstract
Pigment epithelium-derived factor (PEDF) is the most potent inhibitor of angiogenesis, suggesting that loss of PEDF contributes to proliferative diabetic retinopathy. However, the role of PEDF against retinal vascular hyperpermeability remains to be elucidated. We investigated here whether and how PEDF could inhibit the advanced glycation end product (AGE) signaling to vascular hyperpermeability. Intravenous administration of AGEs to normal rats not only increased retinal vascular permeability by stimulating vascular endothelial growth factor (VEGF) expression but also decreased retinal PEDF levels. Simultaneous treatments with PEDF inhibited the AGE-elicited VEGF-mediated permeability by down-regulating mRNA levels of p22phox and gp91phox, membrane components of NADPH oxidase, and subsequently decreasing retinal levels of an oxidative stress marker, 8-hydroxydeoxyguanosine. PEDF also inhibited the AGE-induced vascular hyperpermeability evaluated by transendothelial electrical resistance by suppressing VEGF expression. Furthermore, PEDF decreased reactive oxygen species (ROS) generation in AGE-exposed endothelial cells by suppressing NADPH oxidase activity via down-regulation of mRNA levels of p22PHOX and gp91PHOX. This led to blockade of the AGE-elicited Ras activation and NF-κB-dependent VEGF gene induction in endothelial cells. These results indicate that the central mechanism for PEDF inhibition of the AGE signaling to vascular permeability is by suppression of NADPH oxidase-mediated ROS generation and subsequent VEGF expression. Substitution of PEDF may offer a promising strategy for halting the development of diabetic retinopathy. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
25. Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes
- Author
-
Amano, Shinjiro, Yamagishi, Sho-ichi, Kato, Noriaki, Inagaki, Yosuke, Okamoto, Tamami, Makino, Mitsuhiro, Taniko, Kaori, Hirooka, Hiroko, Jomori, Takahito, and Takeuchi, Masayoshi
- Subjects
- *
ENZYMES , *DIABETIC angiopathies - Abstract
The polyol pathway consists of two enzymes, aldose reductase (AR) and sorbitol dehydrogenase (SDH). There is a growing body of evidence to suggest that acceleration of the polyol pathway is implicated in the pathogenesis of diabetic vascular complications. However, a functional role remains to be elucidated for SDH in the development and progression of diabetic retinopathy. In this study, cultured bovine retinal capillary pericytes were used to investigate the effects of SDH overexpression on glucose toxicity. High glucose modestly increased reactive oxygen species (ROS) generation, decreased DNA synthesis, and up-regulated vascular endothelial growth factor (VEGF) mRNA levels in cultured pericytes. SDH overexpression was found to significantly stimulate ROS generation in high glucose-exposed pericytes and subsequently potentiate the cytopathic effects of glucose. Fidarestat, a newly developed AR inhibitor, and N-acetylcysteine, an antioxidant, completely prevented these deleterious effects of SDH overexpression on pericytes. Furthermore, fidarestat administration was found to significantly prevent vascular hyperpermeability, the characteristic changes of the early phase of diabetic retinopathy, in streptozotocin-induced diabetic rats. Our present results suggest that SDH-mediated conversion of sorbitol to fructose and the resultant ROS generation may play an active role in the pathogenesis of diabetic retinopathy. Blockage of sorbitol formation by fidarestat could be a promising therapeutic strategy for the treatment of early phase of diabetic retinopathy. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
26. Long-term Efficacy and Safety of Upacicalcet in Japanese Hemodialysis Patients with Secondary Hyperparathyroidism: Open-label 52-week Study.
- Author
-
Hamano T, Koiwa F, Isaka Y, Yokoyama K, Fukagawa M, Inagaki Y, Watanabe YS, Honda D, and Akizawa T
- Abstract
Introduction Upacicalcet is a novel injectable calcimimetic. This phase 3 multicenter open-label study aimed to assess the long-term efficacy and safety of upacicalcet in hemodialysis (HD) patients with secondary hyperparathyroidism (SHPT). Methods Japanese HD patients with serum intact parathyroid hormone (iPTH) levels >240 pg/mL and corrected calcium (cCa) levels ≥8.4 mg/dL were enrolled. Upacicalcet with a dose range of 25-300 µg was administered after each dialysis for 52 weeks. The main efficacy endpoint was the percentage of patients achieving the target iPTH level (60-240 pg/mL). Results A total of 157 patients were enrolled, of whom 138 completed the study. Overall, 94.2% of patients achieved the target serum iPTH level at week 52. Neither symptomatic hypocalcemia nor cCa level <7.5 mg/dL occurred despite the negligible increase of concomitant vitamin D receptor activators and calcium carbonate. Upacicalcet improved the control of serum phosphate (P) and calcium levels regardless of baseline PTH levels and decreased intact fibroblast growth factor-23 levels. The largest parathyroid glands shrank, irrespective of their baseline volume or prior calcimimetic usage. Upacicalcet was well-tolerated, with no adverse events requiring dose reduction. Conclusion This is the first study to show that a calcimimetic improves serum P and cCa control without inducing severe hypocalcemia in patients with iPTH levels ≤300 pg/mL. Upacicalcet is efficacious in HD patients with mild-to-severe SHPT, with few safety concerns., (The Author(s). Published by S. Karger AG, Basel.)
- Published
- 2024
- Full Text
- View/download PDF
27. Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling.
- Author
-
Yamagishi S, Abe R, Inagaki Y, Nakamura K, Sugawara H, Inokuma D, Nakamura H, Shimizu T, Takeuchi M, Yoshimura A, Bucala R, Shimizu H, and Imaizumi T
- Subjects
- Animals, Cell Adhesion drug effects, DNA drug effects, DNA metabolism, Endothelium, Vascular drug effects, Endothelium, Vascular metabolism, Female, Humans, Melanoma, Experimental blood supply, Melanoma, Experimental mortality, Mice, Mice, Nude, NADPH Oxidases metabolism, Neovascularization, Pathologic prevention & control, Reactive Oxygen Species metabolism, Signal Transduction drug effects, Signal Transduction physiology, Skin Neoplasms blood supply, Skin Neoplasms mortality, Survival Rate, rac1 GTP-Binding Protein metabolism, Apoptosis drug effects, Diphosphonates therapeutic use, Imidazoles therapeutic use, Melanoma, Experimental prevention & control, Skin Neoplasms prevention & control, Vascular Endothelial Growth Factor A antagonists & inhibitors
- Abstract
Angiogenesis, a process by which new vascular networks are formed from pre-existing capillaries, is required for tumors to grow, invade, and metastasize. Vascular endothelial growth factor (VEGF), a specific mitogen to endothelial cells, is a crucial factor for tumor angiogenesis. In this study, we investigated whether minodronate, a newly developed nitrogen-containing bisphosphonate, could inhibit melanoma growth and improve survival in nude mice by suppressing the VEGF signaling. We found here that minodronate inhibited melanoma growth and improved survival in nude mice by suppressing the tumor-associated angiogenesis and macrophage infiltration. Minodronate completely inhibited the VEGF-induced increase in DNA synthesis and tube formation in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation and Ras activation. Furthermore, minodronate inhibited the VEGF-induced expression of intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in endothelial cells. Minodronate decreased DNA synthesis and increased apoptotic cell death of cultured melanoma cells as well. Our present study suggests that minodronate might suppress melanoma growth and improve survival in nude mice by two independent mechanisms; one is by blocking the VEGF signaling in endothelial cells, and the other is by inducing apoptotic cell death of melanoma. The present study provides a novel potential therapeutic strategy for the treatment of melanoma.
- Published
- 2004
- Full Text
- View/download PDF
28. AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction.
- Author
-
Fukami K, Ueda S, Yamagishi S, Kato S, Inagaki Y, Takeuchi M, Motomiya Y, Bucala R, Iida S, Tamaki K, Imaizumi T, Cooper ME, and Okuda S
- Subjects
- Angiotensin II metabolism, Animals, Cells, Cultured, DNA biosynthesis, Fibronectins metabolism, Glomerular Mesangium cytology, Humans, Male, Rats, Rats, Wistar, Reactive Oxygen Species metabolism, Receptor for Advanced Glycation End Products, Receptors, Immunologic metabolism, Smad Proteins, DNA-Binding Proteins metabolism, Glycation End Products, Advanced pharmacology, Receptor, Angiotensin, Type 1 metabolism, Signal Transduction drug effects, Trans-Activators metabolism, Transforming Growth Factor beta metabolism
- Abstract
Background: The renin-angiotensin system (RAS) and the accumulation of advanced glycation end products (AGEs) have been implicated in the pathogenesis of diabetic nephropathy. Whether there is a functional interaction between the RAS and AGEs in diabetic nephropathy is not known. In this study, we investigated whether AGEs could activate autocrine angiotensin II (Ang II) signaling and subsequently induce transforming growth factor-beta (TGF-beta)-Smad signaling in cultured rat mesangial cells., Methods: The intracellular formation of reactive oxygen species (ROS) was detected using the fluorescent probe CM-H2DCFDA. Ang II was measured by radioimmunoassay. TGF-beta released into media was quantitatively analyzed in an enzyme-linked immunosorbent assay (ELISA). Smad2, p27(Kip1) (p27), fibronectin, and receptor for AGEs (RAGE) protein expression were determined by Western blot analysis. TGF-beta-inducible promoter activity was analyzed by a luciferase assay. DNA synthesis was evaluated by 5-bomo-2'-deoxyuridine (BrdU) incorporation and de novo protein synthesis was determined by [3H]leucine incorporation., Results: AGEs increased intracellular ROS generation in mesangial cells, and this effect was significantly inhibited by an antiserum against RAGE. AGEs also were found to stimulate Ang II production in a time- and dose-dependent manner, which was completely prevented by an antioxidant, N-acetylcysteine (NAC). AGE-induced TGF-beta overproduction was completely blocked by candesartan, an Ang II type 1 receptor (AT1R) antagonist. Both candesartan and neutralizing antibody against TGF-beta completely prevented AGEs-induced Smad2 phosphorylation and TGF-beta-inducible promoter activity. Furthermore, AGEs were found to inhibit DNA synthesis and to stimulate de novo protein synthesis and fibronectin production in association with up-regulation of p27. All of these phenomena were completely prevented by candesartan or a polyclonal antibody against TGF-beta., Conclusion: The present study suggests that AGE-RAGE-mediated ROS generation activates TGF-beta-Smad signaling and subsequently induces mesangial cell hypertrophy and fibronectin synthesis by autocrine production of Ang II. This pathway may provide an important link between metabolic and haemodynamic factors in promoting the development and progression of diabetic nephropathy.
- Published
- 2004
- Full Text
- View/download PDF
29. Azelnidipine, a newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in endothelial cells through its anti-oxidative properties.
- Author
-
Yamagishi S, Inagaki Y, Nakamura K, and Imaizumi T
- Subjects
- Amlodipine pharmacology, Endothelium, Vascular cytology, Endothelium, Vascular metabolism, Humans, In Vitro Techniques, Radioligand Assay, Reactive Oxygen Species metabolism, Reverse Transcriptase Polymerase Chain Reaction, Transcription Factor AP-1 metabolism, Tumor Necrosis Factor-alpha physiology, Umbilical Veins enzymology, Antioxidants pharmacology, Azetidinecarboxylic Acid analogs & derivatives, Azetidinecarboxylic Acid pharmacology, Calcium Channel Blockers pharmacology, Dihydropyridines pharmacology, Endothelium, Vascular drug effects, Interleukin-8 biosynthesis, Tumor Necrosis Factor-alpha pharmacology
- Abstract
Interleukin-8 (IL-8), a member of CXC chemokine family, has been found to play an important role in the pathogenesis of atherosclerosis. Tumor necrosis factor-alpha (TNF-alpha) is involved in the development and progression of atherosclerosis as well. In this study, we investigated whether and how azelnidipine, a newly developed long-acting calcium antagonist, could inhibit TNF-alpha-induced IL-8 expression in human umbilical vein endothelial cells (HUVEC). TNF-alpha significantly increased intracellular reactive oxygen species (ROS) generation in HUVEC, which was completely blocked by azelnidipine or apocynin, an inhibitor of NADPH oxidase. Azelnidipine also completely prevented TNF-alpha-induced increase in NADPH oxidase activity in HUVEC. Further, azelnidipine was found to significantly inhibit activator protein-1 (AP-1) promoter activity and IL-8 expression in TNF-alpha-exposed HUVEC. An inhibitor of AP-1, curcumin, or an anti-oxidant, N-acetylcysteine, also inhibited the TNF-alpha-induced IL-8 expression in HUVEC. These results demonstrated that azelnidipine inhibited TNF-alpha-induced IL-8 expression in HUVEC by blocking NADPH oxidase-mediated ROS generation and subsequent AP-1 activation. Our present study suggests that azelnidipine may play a protective role in the development and progression of atherosclerosis through its anti-oxidative properties.
- Published
- 2004
- Full Text
- View/download PDF
30. Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo.
- Author
-
Abe R, Shimizu T, Yamagishi S, Shibaki A, Amano S, Inagaki Y, Watanabe H, Sugawara H, Nakamura H, Takeuchi M, Imaizumi T, and Shimizu H
- Subjects
- Animals, Apoptosis physiology, Blotting, Western, Cell Line, Tumor, Humans, Mice, Microscopy, Fluorescence, Proteins genetics, Serpins genetics, Transfection, Vascular Endothelial Growth Factor A metabolism, Eye Proteins, Melanoma, Experimental pathology, Neovascularization, Pathologic physiopathology, Nerve Growth Factors, Protein Biosynthesis, Serpins biosynthesis
- Abstract
Pigment epithelium-derived factor (PEDF) has recently been shown to be the most potent inhibitor of angiogenesis in the mammalian eye, and is involved in the pathogenesis of angiogenic eye disease such as proliferative diabetic retinopathy. However, a functional role for PEDF in tumor growth and angiogenesis remains to be determined. In this study, we have investigated both the in vitro and in vivo growth characteristics of human malignant melanoma G361 cell lines, stably transfected to overexpress human PEDF. Expression levels of PEDF proteins in melanoma cell lines G361 and A375 were comparable with that of human cultured melanocytes, whereas vascular endothelial growth factor levels in two tumor cell lines were much stronger than that in normal melanocytes. Overexpression of PEDF was found to significantly inhibit tumor growth and vessel formation in G361 nude mice xenografts. Furthermore, in vitro proliferation rates of G361 cells were decreased in PEDF-transfected cells. PEDF proteins showed dose-dependent induced growth retardation and apoptotic cell death in nontransfected G361 cells, which were completely prevented by treatment with antibodies against the Fas ligand. Our present study highlights two beneficial effects of PEDF treatment on melanoma growth and expansion; one is the suppression of tumor angiogenesis, and the other is induction of Fas ligand-dependent apoptosis in tumor cells. PEDF therefore might be a promising novel therapeutic agent for treatment of patients with melanoma.
- Published
- 2004
- Full Text
- View/download PDF
31. Neurotoxicity of acetaldehyde-derived advanced glycation end products for cultured cortical neurons.
- Author
-
Takeuchi M, Watai T, Sasaki N, Choei H, Iwaki M, Ashizawa T, Inagaki Y, Yamagishi S, Kikuchi S, Riederer P, Saito T, Bucala R, and Kameda Y
- Subjects
- Acetaldehyde chemistry, Acetaldehyde metabolism, Albumins metabolism, Alcoholism metabolism, Alcoholism pathology, Animals, Antibodies metabolism, Apoptosis physiology, Cattle, Cells, Cultured, Cerebral Cortex cytology, Glycation End Products, Advanced chemistry, Glycation End Products, Advanced metabolism, Humans, Neurons cytology, Neurons metabolism, Rabbits, Rats, Acetaldehyde toxicity, Cerebral Cortex metabolism, Glycation End Products, Advanced toxicity, Neurons drug effects
- Abstract
The Maillard reaction that leads to the formation of advanced glycation end products (AGEs) plays an important role in the pathogenesis of angiopathy in diabetic patients, in aging, and in neurodegenerative processes. We hypothesize that acetaldehyde (AA), one of the main metabolites of alcohol, may be involved in alcohol-induced neurotoxicity in vivo by formation of AA-derived AGEs (AA-AGEs) with brain proteins. Incubation of cortical neurons with AA-AGE produced a dose-dependent increase in neuronal cell-death, and the neurotoxicity of AA-AGE was neutralized by the addition of an anti-AA-AGE-specific antibody, but not by anti-N-ethyllysine (NEL) antibody. The AA-AGE epitope was detected in human brain of alcoholism. We propose that the structural epitope AA-AGE is an important toxic moiety for neuronal cells in alcoholism.
- Published
- 2003
- Full Text
- View/download PDF
32. Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells.
- Author
-
Yamagishi S, Inagaki Y, Okamoto T, Amano S, Koga K, and Takeuchi M
- Subjects
- Cells, Cultured, Diabetes Mellitus blood, Dinoprostone metabolism, Humans, Hydrogen Peroxide pharmacology, Intracellular Membranes metabolism, Kidney Tubules, Proximal cytology, Leucine metabolism, RNA, Messenger metabolism, Reactive Oxygen Species, Serum Albumin, Bovine pharmacology, Thymidine metabolism, Transforming Growth Factor beta genetics, Glycation End Products, Advanced pharmacology, Kidney Tubules, Proximal drug effects, Kidney Tubules, Proximal metabolism, Protein Synthesis Inhibitors pharmacology, Transforming Growth Factor beta metabolism
- Abstract
Background: We have shown previously that OPB-9195, a novel inhibitor of advanced glycation end products (AGE), significantly prevented renal tubular injury and tubulointerstitial fibrosis in spontaneous diabetic rats. However, the molecular mechanisms underlying this have not been fully elucidated., Methods: Three immunochemically distinct AGE were prepared by incubating bovine serum albumin (BSA) with glucose, glyceraldehyde, or methylglyoxal. Then, the effects of AGE on human proximal tubular epithelial cells were examined. The intracellular formation of reactive oxygen species (ROS) was detected using the fluorescent probe CM-H2DCFDA. DNA synthesis was evaluated by thymidine uptake, and de novo protein synthesis was determined by [3H]leucine incorporation. Prostaglandin E2 (PGE2) and transforming growth factor-beta (TGF-beta) released into media were quantitatively analyzed in an enzyme-linked immunosorbent assay. TGF-beta gene expression was analyzed by quantitative reverse transcription-polymerase chain reaction (RT-PCR)., Results: When these AGE-BSA were administered to tubular cells, each of them increased generation of intracellular ROS. All of the AGE-BSA, but not non-glycated BSA, were found to induce statistically significant decreases in de novo protein synthesis and PGE2 secretion by tubular cells. Furthermore, AGE-BSA up-regulated the levels of mRNAs for TGF-beta in tubular cells. The structural epitope designated glucose-derived AGE was found to have the greatest cytopathic effects on tubular cells. These AGE-induced inhibition of protein synthesis and PGE2 secretion as well as the up-regulation of TGF-beta mRNA were found to be completely prevented by N-acetylcysteine. Furthermore, H2O2 was shown to inhibit protein synthesis and PGE2 secretion by proximal tubular cells in a dose-dependent manner., Conclusion: The results suggest that AGE inhibits de novo protein synthesis and stimulates TGF-beta mRNA expression in proximal tubular epithelial cells through overgeneration of intracellular ROS. Thus, AGE are involved in the pathogenesis of tubular injury in diabetic nephropathy.
- Published
- 2003
- Full Text
- View/download PDF
33. Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells.
- Author
-
Yamagishi S, Inagaki Y, Okamoto T, Amano S, Koga K, Takeuchi M, and Makita Z
- Subjects
- Acetylcysteine pharmacology, Cell Division, Cells, Cultured, Coculture Techniques, Diabetic Nephropathies metabolism, Glomerular Mesangium cytology, Humans, RNA, Messenger genetics, RNA, Messenger metabolism, Reverse Transcriptase Polymerase Chain Reaction, Tumor Suppressor Protein p53 metabolism, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factors, Apoptosis physiology, Chemokine CCL2 genetics, Endothelial Growth Factors genetics, Glomerular Mesangium metabolism, Glycation End Products, Advanced physiology, Lymphokines genetics
- Abstract
Advanced glycation end products (AGE) have been implicated in the pathogenesis of glomerulosclerosis in diabetes. However, their involvement in the development of the early phase of diabetic nephropathy has not been fully elucidated. We investigated the effects of AGE on growth and on vascular endothelial growth factor (VEGF) and monocyte chemoattractant protein-1 (MCP-1) expression in human cultured mesangial cells. We prepared three immunochemically distinct AGE by incubating bovine serum albumin (BSA) with glucose, glyceraldehyde, or glycolaldehyde. When human mesangial cells were cultured with various types of AGE-BSA, viable cell numbers as well as DNA syntheses were significantly decreased. All of the AGE-BSA were found to significantly increase p53 and Bax protein accumulations and subsequently induce apoptotic cell death in mesangial cells. An antioxidant, N-acetylcysteine, significantly prevented the AGE-induced apoptotic cell death in mesangial cells. Human mesangial cells stimulated prostacyclin production by co-cultured glomerular endothelial cells. Furthermore, various types of AGE-BSA were found to up-regulate the levels of mRNAs for VEGF and stimulate the secretion of VEGF and MCP-1 proteins in mesangial cells. The results suggest that AGE disturbed glomerular homeostasis by inducing apoptotic cell death in mesangial cells and elicited hyperfiltration and microalbuminuria by stimulating the secretion of VEGF and MCP-1 proteins, thereby being involved in the pathogenesis of the early phase of diabetic nephropathy.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.